Form 4: Janux Therapeutics Director Winston Kung Increases Equity Holdings Through RSU and Stock Option Grants

Janux Therapeutics, Inc. Director Winston Kung has reported an increase in his beneficial ownership through the grant of restricted stock units and stock options, aligning his interests with shareholders.

Summary

• Winston Kung, a Director and 10% Owner of Janux Therapeutics, Inc. (JANX), reported transactions on June 11, 2025.
• He acquired 3,750 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• These RSUs will vest on the earlier of June 11, 2026, or the date of the next annual meeting of the Issuer's stockholders, subject to continuous service.
• Following this transaction, Mr. Kung beneficially owns 6,250 shares of Common Stock.
• Additionally, Mr. Kung acquired stock options to purchase 11,667 shares of Common Stock with an exercise price of $25.46 per share.
• These stock options will vest in equal monthly installments over the 12 months following June 11, 2025, or fully vest on the date of the next annual meeting of the Issuer's stockholders, subject to continuous service.
• The stock options have an expiration date of June 10, 2035.
• After this transaction, Mr. Kung beneficially owns 11,667 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Form 4 primarily reports a transaction, the acquisition of equity by a director, even as compensation, generally signals alignment of interests with shareholders and confidence in the company's future, which is a positive indicator.

Positives

• The acquisition of additional equity, through RSUs and stock options, by a director and 10% owner aligns management's interests more closely with those of the shareholders.
• The grants are part of a compensation structure designed to incentivize long-term commitment and performance from key personnel.

Risks

• The vesting of RSUs and stock options is contingent on the reporting person's continuous service, meaning the benefits are not guaranteed if service ceases.

Future Outlook

The future outlook for Winston Kung's equity holdings is tied to the vesting schedules of the granted RSUs and stock options. The RSUs are set to vest by June 11, 2026, or the next annual meeting, while the stock options will vest monthly over 12 months from June 11, 2025, or fully at the next annual meeting, all contingent on continuous service.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the grant of equity compensation to a director. Such grants are common practice across industries, particularly in biotechnology and growth-oriented companies, to attract, retain, and incentivize key talent by aligning their financial interests with long-term company performance.

Related Party Transactions

• The grants of Restricted Stock Units and stock options to Director Winston Kung constitute related party transactions, as they involve compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership through equity grants can be viewed positively as it aligns the director's financial incentives with shareholder value creation.
• Employees: While not directly impacting all employees, such compensation structures for leadership can set a precedent for broader equity incentive programs within the company.

Next Steps

• Vesting of 3,750 Restricted Stock Units on the earlier of June 11, 2026, or the date of the next annual meeting of stockholders, subject to continuous service.
• Monthly vesting of 11,667 stock options over 12 months following June 11, 2025, or full vesting on the date of the next annual meeting of stockholders, subject to continuous service.

Key Dates

Keywords

Janux Therapeutics, JANX, Form 4, Insider Transaction, Winston Kung, Director, Restricted Stock Units, RSU, Stock Options, Equity Grant, Beneficial Ownership